The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction

Journal: Nature Communications

Published: 2017-01-09

DOI: 10.1038/ncomms13946

Affiliations: 5

Authors: 11

Go to article

Research Highlight

Scratching beneath the surface of an itchy condition

© Samira Hohn/EyeEm/Getty

© Samira Hohn/EyeEm/Getty

The protein causing an immune response that causes chronic itchiness has been found.

Atopic dermatitis is an allergic condition that makes the immune system hypersensitive to foreign substances. When these substances are detected, the immune cells release a large quantity of the inflammation-inducing molecule, IL-31, which causes severe itchiness.

A team led by researchers from Kyushu University studied mice with atopic dermatitis and found they carried up to ten times more EPAS1, a protein that responds to low oxygen levels, in their immune cells compared to healthy mice.

They injected EPAS1 into healthy mice and observed increased levels of IL-31, whereas when they engineered mice with atopic dermatitis but restricted EPAS1 activity, IL-31 levels were reduced.

Antihistamines are a common treatment for itchiness, but they do not always work for this symptom of atopic dermatitis. Now, therapeutic targeting of EPAS1 could help soothe the skin of patients with this condition, the authors suggest.

Supported content

  1. Nature Communications 8,13946 (2017). doi: 10.1038/ncomms13946
Institutions FC
Medical Institute of Bioregulation (MIB), Kyushu University, Japan 0.41
School of Medicine / Graduate School of Medical Sciences / Faculty of Medical Sciences, Kyushu University, Japan 0.32
Research Center for Advanced Immunology, Kyushu University, Japan 0.09
Department of Functional Bioscience, Fukuoka Dental College, Japan 0.09
School of Medicine, Fujita Health University, Japan 0.09

Return